Edition:
United Kingdom

Healthcare Facilities & Services

Page 1

Mediclinic implements cost savings programmes in S. Africa, Switzerland

7:00am BST

Oct 17 (Reuters) - Mediclinic International Plc ::FY MARGIN EXPECTATIONS FOR SOUTH AFRICAN BUSINESS (NOT FOR COMPANY) REMAIN IN LINE WITH PREVIOUS GUIDANCE, BROADLY STABLE ON PRIOR YEAR, AT AROUND 21%​.TEAMS IN SOUTH AFRICA, SWITZERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2.

Brookdale ‍says about 20 of co's California communities being affected by wildfires​

Monday, 16 Oct 2017

Oct 16 (Reuters) - Brookdale Senior Living Inc : :Brookdale provides update on the impact of natural disasters; announces leadership change.Brookdale Senior Living Inc - ‍provided an update on impact of hurricanes Harvey and Irma and Northern California wildfires​.Brookdale Senior Living Inc - ‍approximately 20 of company's California communities are being affected by wildfires​.Brookdale Senior Living Inc - ‍expects a negative impact from hurricanes to adjusted EBITDA of about $12 million to $13 million for 2017​.Brookdale Senior Living Inc - ‍so far, none of communities have suffered major damage from wildfires​.Brookdale Senior Living Inc - estimates that to incur additional about $13 million to $14 million of capitalized costs for physical plant remediation.Brookdale - estimates to incur about $5 million to $6 million of physical plant remediation costs during Q4 of 2017 & remainder in 2018​.

NeoGenomics sees Q3 revenue of about $63.1 mln

Thursday, 12 Oct 2017

Oct 12 (Reuters) - NeoGenomics Inc :NeoGenomics announces preliminary quarter 3 results, financial impacts of hurricanes and summary quarter 4 guidance.NeoGenomics Inc - ‍it expects to report quarter 3 revenue of approximately $63.1 million and adjusted EBITDA of approximately $6.0 million​.NeoGenomics Inc - ‍NeoGenomics estimates that hurricanes Harvey and Irma depressed revenue by approximately $1.0 million in quarter 3​.NeoGenomics inc - ‍in addition, as a result of divestiture of pathlogic, Q3 revenue will be approximately $1.3 million less than in quarter 2​.NeoGenomics Inc - ‍expects consolidated revenue of $65 million - $67 million and adjusted EBITDA of $9 million -10 million in Q4​.NeoGenomics-For Q3,expects to record $1.3 million revenue adjustment to reflect change in process for estimating revenue for unbilled tests at quarter-end​.Q3 revenue view $65.9 million -- Thomson Reuters I/B/E/S.Q4 revenue view $69.1 million -- Thomson Reuters I/B/E/S.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary